|
DD120303A1
(cg-RX-API-DMAC7.html)
|
1975-05-15 |
1976-06-05 |
|
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
WO2013174403A1
(en)
*
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2013174404A1
(en)
*
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2016165762A1
(en)
*
|
2015-04-15 |
2016-10-20 |
Ganymed Pharmaceuticals Ag |
Drug conjugates comprising antibodies against claudin 18.2
|
|
ES2979068T3
(es)
*
|
2016-07-08 |
2024-09-24 |
Crage Medical Co Ltd |
Anticuerpos para anti-claudina 18A2 y utilización de los mismos
|
|
JP2021523090A
(ja)
*
|
2018-03-09 |
2021-09-02 |
科済生物医薬（上海）有限公司Ｃａｒｓｇｅｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｏ．，Ｌｔｄ． |
腫瘍を治療するための方法および組成物
|
|
WO2019242505A1
(zh)
*
|
2018-06-17 |
2019-12-26 |
上海健信生物医药科技有限公司 |
靶向cldn18.2的抗体、双特异性抗体、adc和car及其应用
|
|
KR20210050547A
(ko)
*
|
2018-08-27 |
2021-05-07 |
난징 산홈 팔마세우티칼 컴퍼니 리미티드 |
항-클라우딘18.2 항체 및 이의 용도
|
|
JP2022511394A
(ja)
*
|
2018-09-30 |
2022-01-31 |
カファ セラピューティクス リミテッド |
Ｃｌｄｎ１８の抗体及び化学療法薬の併用療法
|
|
EP3872093A4
(en)
*
|
2018-10-22 |
2022-10-19 |
Shanghai Genbase Biotechnology Co., Ltd. |
ANTI-CLDN18.2 ANTIBODIES AND USES THEREOF
|
|
BR112021011014A2
(pt)
*
|
2018-12-07 |
2021-08-31 |
Zlip Holding Limited |
Anticorpos anti-claudina e usos destes
|
|
EP3902824A4
(en)
*
|
2018-12-28 |
2023-01-04 |
Sparx Therapeutics Inc. |
FOR CLAUDIN 18.2 SPECIFIC BINDING MOLECULES, COMPOSITIONS AND METHODS OF TREATMENT OF CANCER AND OTHER DISEASES
|
|
CN109762067B
(zh)
*
|
2019-01-17 |
2020-02-28 |
北京天广实生物技术股份有限公司 |
结合人Claudin 18.2的抗体及其用途
|
|
EP3960766A4
(en)
|
2019-04-19 |
2022-12-07 |
Keymed Biosciences Co.,Ltd. |
ANTI-TUMOR THERAPEUTIC AGENT AND USE THEREOF
|
|
CN114206935B
(zh)
*
|
2019-05-24 |
2024-01-12 |
三优生物医药(上海)有限公司 |
新型cldn18.2结合分子
|
|
KR102777693B1
(ko)
*
|
2019-07-17 |
2025-03-07 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
Claudin18 항체 및 암 치료 방법
|
|
JP7767270B2
(ja)
*
|
2019-08-20 |
2025-11-11 |
スーチョウ トランセンタ セラピューティクス カンパニー，リミテッド |
新規抗ｃｌｄｎ１８．２抗体
|
|
CN112480248B
(zh)
*
|
2020-11-24 |
2023-05-05 |
三优生物医药(上海)有限公司 |
与cld18a2特异性结合的分子
|
|
CN113416260B
(zh)
*
|
2021-04-14 |
2022-02-01 |
南京凯地医疗技术有限公司 |
靶向Claudin18.2的特异性嵌合抗原受体细胞及其制备方法和应用
|